HBFOTC FILING WATCHBY HONGBO FINANCELIVE WIREOFFICIAL SEC RECORDS · FINRA OTC DAILY LIST
公司公告

Silence Therapeutics Highlights Recent Business Achievements and Reports Third Quarter 2026 Financial Results

Silence Therapeutics plc · SLNCF

原披露日期:;精度:秒。

来源:SEC(SEC EDGAR 8-K)。

查看原始披露 ↗

查看已提交的公告附件 ↗

融资准备壳资料工具

原文限定:On October 19, 2026, Silence announced ( press release ) that it has entered into a definitive agreement to be acquired by Merck KGaA, Darmstadt, Germany. The transaction is expected to close in the first quarter of 2027, subject to the satisfaction of customary closing conditions.

原文限定:Total outstanding shares were 186,609,073 ordinary shares (including shares in the form of American Depositary Shares) as of September 30, 2026.

原文限定:(Unaudited, in thousands, except share and per share data)

原文限定:(Unaudited, in thousands, except share and per share data)

标题保留原文的计划、申请、条件、初步结果及否定状态,以原文为准。本站核验来源归属、证券身份及披露时间,不保证公司陈述或投资价值。

核验记录与处理时间

来源原始时间字段:2026-11-12T13:10:20.000Z;日期依据:SEC accepted filing time (Atom and index checked); calendar date is America/New_York; not an inferred press-release time。

采集层首次发现:2026-11-12T13:15:26.831Z;事件路径观察:2026-11-12T13:15:33.762Z。

处理开始:2026-11-12T19:30:53.999Z;处理完成:2026-11-12T19:30:57.889Z;首次资格通过:2026-11-12T19:30:57.889Z;首次公开:2026-11-12T19:30:57.889Z。

公开模式:natural_new;处理方式:automatic;规则版本:sec_company_events_v3_filed_release;自然时槽:2026-11-12T19:30:23.513Z。

保留原始披露及首次时间,重新展示不重写发布时间。

公司身份依据 · OTC市场依据

身份核验记录:2026-11-12T19:30:55.281Z;来源核验记录:2026-11-12T19:30:55.281Z。